Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Ado-Trastuzumab Emtansine
×
Clear all
Filters
2
NCT06663787
2025-11-28
HER2 CR
Nagoya City University
Active not recruiting
50 enrolled